What CBD Products Sell During a Pandemic?

The increased demand for wellness and self-care products during the coronavirus pandemic has made more people curious about trying CBD, even though it has yet to be approved by the Food and Drug Administration.

Separate from the actual virus, quarantine itself brings its own share of ills, such as anxiety, depression, sleeping problems, muscle pain from inactivity and, of course, crippling boredom. Although CBD has not been clinically proven to reduce anxiety, reducing anxiety is a key selling point for CBD, so it makes sense that in a time of public uncertainty more people would be open to experimenting with it.

According to CBD market-research company Brightfield Group, anxiety is the number-one ailment among CBD users. Over half of the users surveyed (53 percent) said they use CBD to manage anxiety, with treatment of depression and insomnia also among the top five reasons.